Post by
GoldenArm on Dec 03, 2021 2:48pm
Hold the line on ARCH
We've seen this before. Sell on news to see if it will dip only to see it rebound at the end of the day. Today is the same thing. They shake to see if anyone will sell, Why, because so few shareholder want to let go of the stock.
ARCH has received a bunch of money for LSALT from governments and will get more. YES the current study is better than Phase 3 because if the results are good after 2 weeks they could get fast tracked through.
A lot of big influential ownership in ARCH and they will see their invenstment bear fruit.
Note: these are my opinons please due you due Diligence and verify and double check before investing. This is not advice just my humble opinion.
Comment by
stocksarefun on Dec 03, 2021 3:01pm
My only issue is a serious lack of demand from new investors. Uplisting to access new pools of investors is fine, but with it also comes an insane amount of trickery from the US funds who want cheap shares as well, no? We should be getting at least a little bit more interest from canadian retail, canadian institutions, AND US retail who closely follow pharma/biotech sectors.